{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:31:39Z","timestamp":1767850299057,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaip.2019.09.032","type":"journal-article","created":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T10:49:33Z","timestamp":1570877373000},"page":"690-695.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea"],"prefix":"10.1016","volume":"8","author":[{"given":"Min-Suk","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heung-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Heon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Up","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-4201","authenticated-orcid":false,"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.09.032_bib1","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.09.032_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.09.032_bib3","series-title":"Principles of epidemiology in public health practice: an introduction to applied epidemiology and biostatistics","author":"Dicker","year":"2006"},{"key":"10.1016\/j.jaip.2019.09.032_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2019.09.032_bib5","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.09.032_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.09.032_bib7","doi-asserted-by":"crossref","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2019.09.032_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"Gu\u00e9gan","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.09.032_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaip.2017.10.033","article-title":"Epidermal necrolysis, ocular complications, and \u201ccold medicines\u201d","volume":"6","author":"Roujeau","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.09.032_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/sim.4780100408","article-title":"Using a claims database to investigate drug-induced Stevens-Johnson syndrome","volume":"10","author":"Strom","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2019.09.032_bib11","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2019.09.032_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2019.09.032_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-016-0048-5","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database","volume":"2","author":"Abe","year":"2016","journal-title":"J\u00a0Pharm Health Care Sci"},{"key":"10.1016\/j.jaip.2019.09.032_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5415\/apallergy.2014.4.1.68","article-title":"Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen","volume":"4","author":"Kim","year":"2014","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2019.09.032_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4168\/aair.2019.11.2.212","article-title":"Phenotypes of severe cutaneous adverse reactions caused by nonsteroidal anti-inflammatory drugs","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2019.09.032_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000354918","article-title":"Clinical features and prognostic factors in severe cutaneous drug reactions","volume":"162","author":"Yang","year":"2013","journal-title":"Int Arch Allergy Imm"},{"key":"10.1016\/j.jaip.2019.09.032_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2019.09.032_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5021\/ad.2008.20.4.260","article-title":"Toxic epidermal necrolysis Induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide","volume":"20","author":"Chun","year":"2008","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2019.09.032_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2019.09.032_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1346-8138.2010.00921.x","article-title":"Stevens-Johnson syndrome induced by acetazolamide","volume":"38","author":"Her","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2019.09.032_bib21","doi-asserted-by":"crossref","first-page":"e2100","DOI":"10.1097\/MD.0000000000002100","article-title":"Trends of antibiotic consumption in Korea according to national reimbursement data (2008-2012)","volume":"94","author":"Yoon","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2019.09.032_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pds.3778","article-title":"Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases","volume":"24","author":"Davis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2019.09.032_bib23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2014.839","article-title":"Recurrence and mortality following severe cutaneous adverse reactions","volume":"311","author":"Finkelstein","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.09.032_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.2014.10777","article-title":"Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"312","author":"Stern","year":"2014","journal-title":"JAMA"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930858X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930858X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:21:55Z","timestamp":1761974515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981930858X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S221321981930858X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.09.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}